Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Cell ; 183(4): 1086-1102.e23, 2020 11 12.
Artigo em Inglês | MEDLINE | ID: mdl-33186521

RESUMO

Strategies for installing authentic ADP-ribosylation (ADPr) at desired positions are fundamental for creating the tools needed to explore this elusive post-translational modification (PTM) in essential cellular processes. Here, we describe a phospho-guided chemoenzymatic approach based on the Ser-ADPr writer complex for rapid, scalable preparation of a panel of pure, precisely modified peptides. Integrating this methodology with phage display technology, we have developed site-specific as well as broad-specificity antibodies to mono-ADPr. These recombinant antibodies have been selected and characterized using multiple ADP-ribosylated peptides and tested by immunoblotting and immunofluorescence for their ability to detect physiological ADPr events. Mono-ADPr proteomics and poly-to-mono comparisons at the modification site level have revealed the prevalence of mono-ADPr upon DNA damage and illustrated its dependence on PARG and ARH3. These and future tools created on our versatile chemical biology-recombinant antibody platform have broad potential to elucidate ADPr signaling pathways in health and disease.


Assuntos
ADP-Ribosilação , Proteínas de Transporte/metabolismo , Proteínas Nucleares/metabolismo , Poli(ADP-Ribose) Polimerase-1/metabolismo , ADP-Ribosilação/efeitos dos fármacos , Sequência de Aminoácidos , Anticorpos/metabolismo , Benzimidazóis/farmacologia , Linhagem Celular Tumoral , Técnicas de Visualização da Superfície Celular , Dano ao DNA , Glicosídeo Hidrolases/metabolismo , Histonas/metabolismo , Humanos , Fosfatos/metabolismo , Monoéster Fosfórico Hidrolases/metabolismo , Ftalazinas/farmacologia , Piperazinas/farmacologia , Poli(ADP-Ribose) Polimerase-1/química , Proteínas Recombinantes/metabolismo , Serina/metabolismo , Tirosina/metabolismo
2.
Elife ; 4: e11620, 2015 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-26673079

RESUMO

Dinitrogen reduction in the biological nitrogen cycle is catalyzed by nitrogenase, a two-component metalloenzyme. Understanding of the transformation of the inert resting state of the active site FeMo-cofactor into an activated state capable of reducing dinitrogen remains elusive. Here we report the catalysis dependent, site-selective incorporation of selenium into the FeMo-cofactor from selenocyanate as a newly identified substrate and inhibitor. The 1.60 Å resolution structure reveals selenium occupying the S2B site of FeMo-cofactor in the Azotobacter vinelandii MoFe-protein, a position that was recently identified as the CO-binding site. The Se2B-labeled enzyme retains substrate reduction activity and marks the starting point for a crystallographic pulse-chase experiment of the active site during turnover. Through a series of crystal structures obtained at resolutions of 1.32-1.66 Å, including the CO-inhibited form of Av1-Se2B, the exchangeability of all three belt-sulfur sites is demonstrated, providing direct insights into unforeseen rearrangements of the metal center during catalysis.


Assuntos
Azotobacter vinelandii/enzimologia , Molibdoferredoxina/metabolismo , Nitrogenase/metabolismo , Selênio/metabolismo , Azotobacter vinelandii/química , Domínio Catalítico , Cristalografia por Raios X , Cianatos/metabolismo , Modelos Moleculares , Molibdoferredoxina/química , Conformação Proteica , Compostos de Selênio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA